Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-03-04

Clinical Trial Update: Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating the effect of exercise in people with rheumatoid arthritis who are taking anti-TNF alpha medications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-TNF alpha medications (tumor necrosis factor inhibitors)

Snippet

Sponsor: University College Dublin | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: UNKNOWN